Posts Feed
Comments Feed

Covidien Receives FDA Clearance To Market Single-Incision Laparoscopic Surgery (SILS(TM)) Kit

Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, announced that its Surgical Devices business unit has received FDA 510(k) clearance to market the Covidien SILS? Procedure Kit, indicated for Single-Incision Laparoscopic Surgery and other advanced laparoscopic procedures.

More: continued here

No Comments »

Trackback URI | Comments RSS

Leave a Reply

You must be logged in to post a comment.

1